Public consultation on a clinical trial with the gen. modified...
(WorldNews Europe)

The FPS Health and the FAMHP invite you to participate in the public consultation on a clinical trial with the genetically modified medicinal product Talimogene Laherparepvec. The purpose of this trial is to determine the safety and efficacy of Talimogene Laherparepvec in pediatric subjects with advanced non-central nervous system (CNS) tumors that are amenable to direct injection....